PortfoliosLab logoPortfoliosLab logo
ESLT vs. MEDP
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ESLT vs. MEDP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Elbit Systems Ltd (ESLT) and Medpace Holdings, Inc. (MEDP). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ESLT achieves a 43.85% return, which is significantly higher than MEDP's -18.47% return.


ESLT

1D
0.83%
1M
6.13%
YTD
43.85%
6M
71.50%
1Y
98.59%
3Y*
60.25%
5Y*
45.92%
10Y*
25.96%

MEDP

1D
0.80%
1M
8.00%
YTD
-18.47%
6M
-16.62%
1Y
54.44%
3Y*
30.12%
5Y*
21.82%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

ESLT vs. MEDP - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ESLT
Elbit Systems Ltd
43.85%125.14%22.17%31.30%-4.82%34.77%-14.56%37.62%-13.22%32.65%
MEDP
Medpace Holdings, Inc.
-18.47%69.05%8.38%44.31%-2.40%56.35%65.60%58.81%45.97%0.53%

Correlation

The correlation between ESLT and MEDP is 0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.03

Correlation (3Y)
Calculated over the trailing 3-year period

0.08

Correlation (5Y)
Calculated over the trailing 5-year period

0.14

Correlation (All Time)
Calculated using the full available price history since Aug 12, 2016

0.20

The correlation between ESLT and MEDP shifts across timeframes, from 0.03 (1 year) to 0.20 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

ESLT:

$39.95B

MEDP:

$13.26B

EPS

ESLT:

$12.36

MEDP:

$15.63

PE Ratio

ESLT:

67.15

MEDP:

29.29

PEG Ratio

ESLT:

3.18

MEDP:

0.88

PS Ratio

ESLT:

4.80

MEDP:

5.04

PB Ratio

ESLT:

9.38

MEDP:

22.17

Total Revenue (TTM)

ESLT:

$8.23B

MEDP:

$2.68B

Gross Profit (TTM)

ESLT:

$2.03B

MEDP:

$778.59M

EBITDA (TTM)

ESLT:

$861.06M

MEDP:

$572.96M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ESLT vs. MEDP — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ESLT
ESLT Risk / Return Rank: 9090
Overall Rank
ESLT Sharpe Ratio Rank: 9292
Sharpe Ratio Rank
ESLT Sortino Ratio Rank: 9191
Sortino Ratio Rank
ESLT Omega Ratio Rank: 8888
Omega Ratio Rank
ESLT Calmar Ratio Rank: 8888
Calmar Ratio Rank
ESLT Martin Ratio Rank: 8989
Martin Ratio Rank

MEDP
MEDP Risk / Return Rank: 7373
Overall Rank
MEDP Sharpe Ratio Rank: 6868
Sharpe Ratio Rank
MEDP Sortino Ratio Rank: 7373
Sortino Ratio Rank
MEDP Omega Ratio Rank: 8282
Omega Ratio Rank
MEDP Calmar Ratio Rank: 7070
Calmar Ratio Rank
MEDP Martin Ratio Rank: 6969
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ESLT vs. MEDP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Elbit Systems Ltd (ESLT) and Medpace Holdings, Inc. (MEDP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ESLTMEDPDifference
Sharpe ratioReturn per unit of total volatility

+1.56

Sortino ratioReturn per unit of downside risk

+1.42

Omega ratioGain probability vs. loss probability

1.39

1.32

+0.07

Calmar ratioReturn relative to maximum drawdown

3.82

1.49

+2.32

Martin ratioReturn relative to average drawdown

10.82

3.38

+7.44

ESLT vs. MEDP - Sharpe Ratio Comparison

The current ESLT Sharpe Ratio is 2.35, which is higher than the MEDP Sharpe Ratio of 0.79. The chart below compares the historical Sharpe Ratios of ESLT and MEDP, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


ESLTMEDPDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.35

0.79

+1.56

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

1.39

0.43

+0.97

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.89

Sharpe Ratio (All Time)

Calculated using the full available price history

0.62

0.67

-0.05

Drawdowns

ESLT vs. MEDP - Drawdown Comparison

The maximum ESLT drawdown since its inception was -53.79%, which is greater than MEDP's maximum drawdown of -42.87%. Use the drawdown chart below to compare losses from any high point for ESLT and MEDP.


Loading charts...

Drawdown Indicators


ESLTMEDPDifference

Max Drawdown

Largest peak-to-trough decline

-53.79%

-42.87%

-10.92%

Max Drawdown (1Y)

Largest decline over 1 year

-25.98%

-36.61%

+10.63%

Max Drawdown (3Y)

Largest decline over 3 years

-25.98%

-39.38%

+13.40%

Max Drawdown (5Y)

Largest decline over 5 years

-32.89%

-42.87%

+9.98%

Max Drawdown (10Y)

Largest decline over 10 years

-32.89%

Current Drawdown

Current decline from peak

-18.07%

-26.22%

+8.15%

Average Drawdown

Average peak-to-trough decline

-13.92%

-12.91%

-1.01%

Ulcer Index

Depth and duration of drawdowns from previous peaks

9.14%

16.16%

-7.02%

Volatility

ESLT vs. MEDP - Volatility Comparison

Elbit Systems Ltd (ESLT) has a higher volatility of 15.36% compared to Medpace Holdings, Inc. (MEDP) at 6.61%. This indicates that ESLT's price experiences larger fluctuations and is considered to be riskier than MEDP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ESLTMEDPDifference

Volatility (1M)

Calculated over the trailing 1-month period

15.36%

6.61%

+8.75%

Volatility (6M)

Calculated over the trailing 6-month period

33.61%

37.78%

-4.17%

Volatility (1Y)

Calculated over the trailing 1-year period

42.26%

69.11%

-26.85%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

33.13%

51.61%

-18.48%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

29.13%

49.80%

-20.67%

Dividends

ESLT vs. MEDP - Dividend Comparison

ESLT's dividend yield for the trailing twelve months is around 0.37%, while MEDP has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
ESLT
Elbit Systems Ltd
0.37%0.47%0.77%0.94%1.22%1.03%1.28%1.14%1.54%1.32%1.57%1.63%
MEDP
Medpace Holdings, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

ESLT vs. MEDP - Financials Comparison

This section allows you to compare key financial metrics between Elbit Systems Ltd and Medpace Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B5.00B20222023202420252026
2.19B
706.60M
(ESLT) Total Revenue
(MEDP) Total Revenue
Values in USD except per share items

ESLT vs. MEDP - Profitability Comparison

The chart below illustrates the profitability comparison between Elbit Systems Ltd and Medpace Holdings, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

24.0%26.0%28.0%30.0%32.0%34.0%20222023202420252026
25.2%
27.8%
Portfolio components
ESLT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Elbit Systems Ltd reported a gross profit of 552.06M and revenue of 2.19B. Therefore, the gross margin over that period was 25.2%.

MEDP - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Medpace Holdings, Inc. reported a gross profit of 196.33M and revenue of 706.60M. Therefore, the gross margin over that period was 27.8%.

ESLT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Elbit Systems Ltd reported an operating income of 205.13M and revenue of 2.19B, resulting in an operating margin of 9.4%.

MEDP - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Medpace Holdings, Inc. reported an operating income of 141.50M and revenue of 706.60M, resulting in an operating margin of 20.0%.

ESLT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Elbit Systems Ltd reported a net income of 160.79M and revenue of 2.19B, resulting in a net margin of 7.4%.

MEDP - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Medpace Holdings, Inc. reported a net income of 123.87M and revenue of 706.60M, resulting in a net margin of 17.5%.


Frequently Asked Questions


ESLT and MEDP have a correlation of 0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ESLT has higher volatility (15.36%) compared to MEDP (6.61%). In terms of maximum drawdown, ESLT dropped -53.79% vs MEDP's -42.87%.

ESLT currently has the higher Sharpe Ratio (2.35 vs 0.79), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ESLT and MEDP

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer